Dennis D. Kim - 28 Mar 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role: Chief Medical Officer
Signature: /s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim
Issuer symbol: N/A
Transactions as of: 28 Mar 2023
Net transactions value: -$462
Form type: 4
Filing time: 30 Mar 2023, 17:39:49 UTC
Previous filing: 27 Jan 2023
Next filing: 17 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CBAY	Common Stock	Options Exercise	$437	+100	+0.5%	$4.37	20,100	28 Mar 2023	Direct
transaction	CBAY	Common Stock	Sale	$898	-100	-0.5%	$8.98	20,000	28 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CBAY	Employee Stock Option (right to buy)	Options Exercise	$0	-100	-0.03%	$0.000000	289,900	28 Mar 2023	Common Stock	100	$4.37	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.